Graft and patient survival outcomes following split liver transplantation (SLT), living-donor liver transplantation (LDLT) and deceased-donor liver transplantation (DDLT) were estimated using Bayesian network meta-analysis. Databases were searched for relevant articles over the previous 20 years (MEDLINE, Embase, Cochrane Library and Google Scholar). Systematic review, pairwise meta-analysis and Bayesian network meta-analysis were performed. Pairwise meta-analysis demonstrated that there were no significant differences in graft and patient survival outcomes. Consequently, Bayesian network meta-analysis demonstrated no significant differences in 1-, 3-and 5-year graft and patient survival between the three alternative liver transplantations. No discrepancies were demonstrated after comparisons of direct and indirect evidence of 1-, 3-and 5-year patient and graft survival of the three node-split models namely SLT, LDLT and DDLT. The 1-, 3-and 5-year graft and patient survival of the SLT and LDLT cohorts compared to the DDLT cohort demonstrated no significant differences. The direct and indirect evidence of this study can serve as comparator for future studies.
Introduction
The need for potential recipients for liver transplantation has always exceeded the size of the donor pool. The waiting list mortality among patients waiting for liver transplantation is 10-20% [1] . It has been reported that split liver transplantation (SLT) involves only 1.3% of the deceased-donor liver transplantation (DDLT) [2] . Development of SLT was associated with significantly reduced waiting list times among paediatric recipients older than 1 year, ranging from 192 to 30 days [3] . In countries, where DDLT is prohibited or limited, livingdonor liver transplantation (LDLT) has become the standard for liver transplantation. However, in countries where both SLT and LDLT are possible, there is debate over the appropriateness of these techniques.
Both SLT and LDLT present some form of compromise over DDLT. Developing LDLT programmes among those countries where SLT is practiced raises ethical issues due to the inherent risk to the living donors.
However, given the shortage of donor organs among adult and paediatric recipients, these techniques remain viable ways to increase the donor pool.
Consequently, comparing outcomes between recipients of SLT, LDLT and DDLT is therefore necessary to form an argument for or against these procedures. To date, there are data of direct comparisons of SLT versus DDLT and LDLT versus DDLT mainly from retrospective studies . However, there is a clear paucity of data with limited direct comparisons between recipients of SLT and LDLT. Only one retrospective study reported on the 1-, 3-and 5-year graft and patient survival of SLT versus LDLT [25] . This paucity of direct evidence can be tackled with the estimation of the indirect evidence using the methods of the network metaanalysis [29, 30] . Thus, the estimated indirect evidence can be compared with the existing and future direct evidence [29, 30] .
The aim of this study was to compare the survival benefit between adult recipients of SLT, LDLT and DDLT using Bayesian network meta-analysis.
Methods
The PRISMA Statement checklist for reporting systematic review and meta-analysis was followed in this study.
Literature search
Using both free text and MESH terms (right lobe split liver transplantation; living-donor liver transplantation; deceased-donor liver transplantation; whole-liver transplantation), a systematic search of the literature was performed in MEDLINE, Embase, PubMed and Google Scholar databases from their inception up to February 2018 [Appendix 1]. Abstracts were selected. References of the retrieved articles were checked manually for further studies. Any discrepancies regarding the study selection were resolved by discussion between the authors.
Study selection, and inclusion and exclusion criteria
Only studies that compared (i) right lobe SLT versus whole-liver transplantation (WLT), (ii) right lobe SLT versus LDLT and (iii) LDLT versus DDLT were included in the review. Excluded studies were studies with less than 12 patients in each arm and studies that did not accurately describe the splitting method. The most recent publication was chosen from the overlapped studies. Time, language and region restrictions were not applied to the systematic review.
Data extraction and outcomes
Two researchers (PG and KR) independently extracted the following summary data for the included studies: name of authors; country; number of patients included in SLT, LDLT and DDLT; age of recipient; sex of recipient; model for end-stage liver disease (MELD) score; and 1-, 3-and 5-year patient and graft survival rates. Patient and graft survival rates were the primary outcome measures for the three procedures.
Statistical analysis
The methodological quality of all included studies was assessed using the validated Newcastle-Ottawa scale (NOS) [31] . Studies scoring ≥7 were considered of high quality.
First, a pairwise meta-analysis was performed for studies that compared two transplantation approaches. Subsequently, a Bayesian network meta-analysis was conducted to compare SLT, LDLT and DDLT. Statistical analysis was conducted using both Stata software (version 15; Stata Corp LP, College Station, TX, USA) and General mixed treatments comparisons (GeMTC) software [32, 33] . Dichotomous variables were analysed based on odds ratios (ORs) with 95% confidence intervals (CI). Analysis of long-term survival was performed by combining the hazard ratios (HRs) and 95% CIs from the included studies. These were rarely reported and thus were estimated using the method described by Parmar et al. [34] , where possible. For studies that reported the numbers at risk, these were combined with either the quoted survival rates or values read from enlarged plots of the Kaplan-Meier curves to produce the estimates. Where numbers at risk were not quoted, constant censoring over the period of follow-up was assumed in the estimation.
For all analyses, the point estimate was considered significant at P < 0.05.
Bayesian network meta-analysis was performed using hierarchical random-effects models [30] . A fixed-effects model was also used to estimate whether any discrepancy could be demonstrated between the results of the two models. Quantitative data synthesis of the connected network of the studies was conducted using the software package WinBUGS (version 1.4.3; MRC Biostatistics Unit, Cambridge, UK) [33, 35] . The pooled estimates were obtained using the Markov chain Monte Carlo method. Minimally informative priors with vague normal prior distributions were used [35] . For each model, 200 000 simulations were generated for the two sets of different initial values, and the first 5000 were discarded as the burn-in period. The Brooks-Gelman-Rubin statistic was used for the assessment of convergence [35] . The point estimate was defined as the median of the posterior distribution based on 200,000 simulations; the corresponding 95% credible intervals (CrIs) were obtained using the 2.5th and 97.5th percentiles of the posterior distribution, which can be interpreted in a similar way as 95% CIs [35] . Inconsistency and heterogeneity of the direct and indirect evidence for the three surgical approaches were estimated.
The node-splitting method was used to calculate the inconsistency of the model, which separated evidence into direct and indirect; then, the agreement between the two was evaluated and reported with Bayesian values [33, 36, 37] . The diagnostic information criterion (DIC), random-effects standard deviation (RESD) and effect estimates from direct and indirect evidence were displayed for convenient assessment.
Results

Search strategy and study characteristics
Twenty-six studies, which included 13 374 patients, were selected from a pool of 739 studies . Among these, patients that underwent liver transplantation were distributed as follows: SLT 1329 (10%), LDLT 3469 (26%) and DDLT 8576 (64%). From the 43 full-text assessed papers, 17 were excluded for the following reasons; three articles overlapped with the previous publications; and 14 did not clearly describe the splitting graft types (Fig. 1) 
Patient and donor demographics
No differences were observed in the demographic characteristics of the recipients between the SLT, LDLT and DDLT cohort. However, the donors for SLT were significantly younger by 12 years [mean difference (MD) À12.06 years, 95% CI À16.29 to À7.83, P < 0.001, I 2 = 91%] (Table 1) .
Results from pairwise meta-analysis
Graft survival
There were no significant differences between the SLT and DDLT cohorts in terms of 1-, 3-and 5-year graft survival (HR 0.98, 95% CI 0.93-1.03, P = 0.42, I 2 = 22%), (HR 1.05, 95% CI 0.79-1.38, P = 0.74, I 2 = 95%), (HR 1.04, 95% CI, 0.98-1.11, P = 0.20, I 2 = 12%), respectively (Fig. S1) .
Similarly, there was no significant difference between the LDLT cohort and DDLT cohort in 1-, 3-and 5-year graft survival (HR 0.92, 95% CI 0.44-1.94, P = 0.83, I 2 = 89%; HR 0.98, 95% CI 0.61-1.39, P = 0.94, I 2 = 65%; and HR 1.01, 95% CI 0.80-1.28, P = 0.93, I 2 = 0%), respectively (Fig. S1 ).
Furthermore, there was no significant difference in 1-year graft survival between the SLT and LDLT cohorts (HR 0.94, 95% CI, 0.23-3.79, P = 0.93, I 2 = 0%) ( Fig. S1 ).
Patient survival
No significant differences were demonstrated in 1-, 3-and 5-year patient survival between the SLT and DDLT cohorts (HR 1.00, 95% CI 0.93-1.09, P = 0.92, I 2 = 54%; HR 0.95, 95% CI 0.89-1.01, P = 0.12, I 2 = 0%; and HR 1.02, 95% CI 0.96-1.09, P = 0.48, I 2 = 0%), respectively.
Similarly, no significant differences were demonstrated in 1-, 3-and 5-year patient survival between the LDLT and DDLT cohorts (HR 1.12, 95% CI, 0.96-1.31, P = 0.14, I 2 = 4%; HR 0.90, 95% CI 0.68-1.20, P = 0.48, I 2 = 45%; and HR 0.86, 95% CI 0.72-1.03, P = 0.10, I 2 = 19%), respectively. There was no significant difference in 1-year patient survival between the SLT and LDLT cohorts (HR 1.06, 95% CI 0.87-1.28, P = 0.59, I 2 = 0%) (Fig. S2) .
Fitness of the model, node-splitting analysis
The network of evidence of the three liver transplantations was demonstrated with a closed loop (triangle) (Fig. S7 ). Evaluation of inconsistency using loop-specific heterogeneity was estimated to be nonsignificant [relative odds ratio (ROR) 1.15, 95% CI 1.00-1.69; heterogeneity s 2 = 0.005] (Fig. S3 ). In addition, the random-effects standard deviation = 0.0592 and time-series standard error = 0.0004 supported the consistency of the model. First, the arbitrary starting values did not have an undue influence on the sampling process and secondly, the quantities of interest had been estimated to sufficient accuracy. The time-series plot demonstrated a converged chain that contained sufficient information for accurate inferences; the potential scale reduction factor (PSRF) reached stable values below 1.01 and the series plot of the estimation accuracy showed density and tapering of the extreme values in the tails (Fig. S4) . Furthermore, no inconsistency of the model was found using the node-splitting method. An agreement between direct and indirect evidence among the three node-split models was found (Figs S5 and S6).
Results from network meta-analysis
Graft survival
There were no significant differences in 1-year graft survival between SLT, LDLT and DDLT, SLT versus DDLT (HR 1.02, 95% CrI 0.72-1.47); LDLT versus DDLT (HR 0.93, 95% CrI 0.64-1.42); and SLT versus LDLT (HR 0.97, 95% CrI 0.56-1.52).
Similarly, there were no significant differences in the 3-year graft survival between SLT, LDLT and DDLT: SLT versus DDLT (HR 1.08, 95% CrI 0.74-1.59); SLT versus DDLT (HR 0.92, 95% CrI 0.57-1.41); and LDLT versus DDLT (HR 0.85, 95% CrI 0.50-1.38).
In addition, there was no significant difference in the 5-year graft survival between SLT, LDLT and DDLT: SLT versus DDLT (HR 1.04, 95% CrI 0.95-1.14), LDLT versus DDLT (HR 1.03, 95% CrI 0.87-1.22) and SLT versus LDLT (HR 0.98; CrI 0.83-1.16), (Fig. 2) .
Indirect evidence for graft survival
There was no significant difference between the direct and indirect evidence in 1-, 3-and 5-year survival based on the node-split models for SLT versus DDLT, SLT versus LDLT and LDLT versus DDLT (Fig. S5 ).
Patient survival
There was no difference in 1-year patient survival between SLT, LDLT and DDLT: SLT versus DDLT (HR 1.01, 95% CrI 0.91-1.13), LDLT versus DDLT (HR 1.05, 95% CrI 0.89-1.2) and SLT versus LDLT (HR 1.03, 95% CrI 0.86-1.22), respectively.
Similarly, there was no difference in the 3-year patient survival between SLT, LDLT, and DDLT, SLT versus DDLT (HR 0.96, 95% CrI: 0.82-1.14), LDLT versus DDLT (HR 0.92, 95% CrI 0.75-1.14) and SLT versus LDLT (HR 0.95, 95% CrI 0.76-1.21). In addition, there was no difference in 5-year patient survival between SLT, LDLT and DDLT, SLT versus WLT (HR 1.02, 95% CrI 0.94-1.10), LDLT versus DDLT (HR 0.97, 95% CrI 0.83-1.12) and SLT versus LDLT (HR 0.95, 95% CrI 0.81-1.10), (Fig. 3) .
Indirect evidence of patient survival
There was no significant difference between direct and indirect evidence for 1-, 3-and 5-year survival based on the three node-split models of the SLT versus DDLT, SLT versus LDLT and LDLT versus DDLT (Fig. S6) .
Discussion
The present study compared survival outcomes among adult patients who underwent SLT, LDLT and DDLT. The survival outcomes were first estimated and compared with pairwise meta-analysis, and then with network meta-analysis using Bayesian statistics, and finally using effect estimates of direct and indirect evidence.
The pairwise meta-analysis demonstrated that there were no significant differences in graft and patient survival between the three head to head comparisons. So far, there is a paucity of studies comparing SLT versus LDLT. Only two studies have provided data about this comparison, and the estimated direct evidence demonstrated no significant differences [19, 25] . In the current study, for the first time to our knowledge, the indirect evidence of the three alternative liver transplantations was estimated using Bayesian network meta-analysis. Noteworthy, the indirect evidence for the node-split model comparing SLT versus LDLT showed no significant differences. Moreover, comparison of the direct and indirect evidence for graft and patient survival did not demonstrate any discrepancy. In addition, comparison of the Bayesian values, DIC and RESD, demonstrated consistency of the model. Similarly, the model evaluating the SLT versus DDLT and LDLT versus DDLT did not demonstrate any significant discrepancies between direct and indirect evidence for graft and patient survival.
Many factors have been suggested to be associated with recipient survival after SLT; these include recipient health status at transplantation, elevated donor gamma glutamyl transferase (GGT) level, graft steatosis, graft- to-recipient body weight ratio, intensive care unit stay and total hospital stay [38] . Given the risk profile of transplanting split grafts, previous studies have attempted to define splitting criteria involving donors for one adult and one paediatric recipient. These include age between 14 and 50 years, weight over 45 kg, BMI ≤26, intensive care unit stay ≤3 days, mean arterial pressure ≥60 mmHg, sodium levels ≤160 mmol/l, serum glutamic transaminase (SGPT) ≤60, GGT ≤50; of note, when the donor weight exceeded 70 kg, two adult recipients were preferred. Modelling demonstrated that if splitting criteria applied only to optimal donors, there would be an increase in the number of paediatric donors by 15% and adults by 8.6%. Within the same model, if donor age was increased to 60 years, then the additional increase would be 6% and 2.4% for paediatrics and adult donors, respectively [39] . 
Limitations
The results of this study should be interpreted cautiously because the included studies are all retrospective analyses from single centres and a heterogeneous splitting procedure was used in SLT. Moreover, the results may be influenced by national and institutional characteristics and practice. Furthermore, this study only estimated the survival outcomes because of the lack of data on postoperative complications that could have been used for meta-analysis. Many centres, especially those without high volume of patients, were more likely to be cautious with patient selection of for SLT and LDLT. The new Italian allocation criteria allowed for the potential allocation of partial grafts to less acutely ill patients [39] . The aetiologies of hepatic diseases and the definitions of the complications may vary across the different studies because no international validated classification tool like Clavien-Dindo has been used by the authors of the included studies. Therefore, all of these may have added bias to our outcomes. Risk adjustment of donor and recipient factors is needed to accurately determine benefit, harm or equivalence of one technique over another. Various factors related to reduced graft and recipient survival of split grafts have been reported [40] . Modelling based upon this data has been used to estimate changes to the size of the donor pool based upon changes in definitions of SLT criteria. An international registry of SLT and LDLT could serve a similar purpose to better define donor and recipient cohorts in detail and permit an in-depth assessment of outcomes. Until then, this network meta-analysis presents the most thorough assessment of survival outcomes to date.
Conclusions
In conclusion, SLT and LDLT cohorts demonstrated equivalent graft and recipient survival compared to DDLT. The direct and indirect evidence of this study can serve as comparator for findings of future studies.
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